Search results

Media statement from ANSTO.

Production of nuclear medicine generators has resumed, with all relevant quality control checks passed, and medicine to be distributed across Australia from Sunday 25th October 2020.

The Australian Nuclear Science and Technology Organisation (ANSTO) has joined a team, lead by the US Department of Energy’s Pacific Northwest National Laboratory (PNNL), to install a high resolution monitoring system at ANSTO’s medical isotope production facility in Lucas Heights, Australia.

This month ANSTO is opening its doors to 11 talented young people from across Australia as the two-year Graduate Program kickstarts.

Highlighting the contribution of four inspirational ANSTO leaders on International Women's Day.

In 2023 we’re celebrating the 70th Anniversary since Australia began developing our nation’s Australia’s nuclear capabilities.

ANSTO has safely managed its radioactive waste for over 60 years. Waste is managed in accordance with national and international standards.

Explore ANSTO's range of publications and reports available for the public.

ANSTO is an experienced provider of Teacher Professional Development for Australian and International teachers and our courses cover a wide range of topics. Hear from expert speakers, receive new education resources, and develop lessons for your own class.

The Government is safeguarding Australia’s sovereign capability to produce vital nuclear medicines by launching a $30 million project to design a new world-leading manufacturing facility to be built at Lucas Heights in Sydney.

The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.

The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.

Australia’s new state-of-the-art nuclear medicine facility gets green light.

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.

The final report on the safety of Building 23 by the independent expert review team has been completed.